The Rapid Review Panel (RRP) has reviewed 37 products in three meetings since May 2007.
Four products have demonstrated sufficient basic research and development, validation and recent in-use evaluations to enable the RRP to make a recommendation to the Department that the product should be made available to national health service bodies. This is a recommendation one.
Four products have been awarded a recommendation two stating that basic research and development has been completed and the product may have potential value; in use evaluations/trials are now needed in an NHS clinical setting. However, it is not within the remit of the RRP to clinically evaluate or undertake the evaluation of products within the NHS.